| Followers | 4045 |
| Posts | 152978 |
| Boards Moderated | 3 |
| Alias Born | 08/05/2009 |
Tuesday, December 20, 2022 12:32:39 PM
https://finviz.com/quote.ashx?t=ICCM&p=d
36m OS
10m float
100M VOLUME
the explanation is hidden secret
the reason why people arent honest with the government is because the government isnt honest with people
36m OS
10m float
100M VOLUME
the explanation is hidden secret
the reason why people arent honest with the government is because the government isnt honest with people
Recent ICCM News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/19/2026 12:45:22 PM
- IceCure's ProSense® Reports Nearly 90% Recurrence-Free Rate for Cryoablation of Kidney Cancer: Data Presented at ECIO 2026 and First-Ever Breast Cryoablation Master Class Overbooked • PR Newswire (US) • 05/19/2026 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/18/2026 12:01:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/18/2026 12:01:20 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/18/2026 12:00:34 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/13/2026 09:00:01 PM
- IceCure Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement • PR Newswire (US) • 05/13/2026 08:30:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/12/2026 09:05:48 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/12/2026 08:11:36 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/12/2026 01:28:03 PM
- IceCure Reports First Quarter 2026 Financial Results: ProSense® Sales Increase Substantially in the U.S. and North America • PR Newswire (US) • 05/12/2026 12:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/11/2026 08:02:07 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/06/2026 08:29:51 PM
- IceCure Medical to Report First Quarter 2026 Financial and Operating Results on May 12, 2026 • PR Newswire (US) • 05/06/2026 12:30:00 PM
- IceCure Showcases ProSense® Cryoablation at American Society of Breast Surgeons 2026 Annual Meeting as Commercial Momentum Accelerates in the U.S. Market • PR Newswire (US) • 05/05/2026 12:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/22/2026 09:28:16 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/21/2026 12:45:12 PM
- IceCure Participates in Society of Breast Imaging Symposium 2026 as U.S. ProSense® Revenue Increases by 30%+ in First Quarter of 2026 Compared to First Quarter of 2025 • PR Newswire (US) • 04/21/2026 12:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/13/2026 04:15:25 AM
- Form F-1 - Registration statement for certain foreign private issuers • Edgar (US Regulatory) • 04/01/2026 08:30:39 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/27/2026 12:49:33 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/27/2026 10:11:32 AM
- IceCure Announces Pricing of $4.0 Million Registered Direct Offering and Concurrent Private Placement • PR Newswire (US) • 03/26/2026 12:00:00 PM

